{
    "id": 6496,
    "name": "extraskeletal myxoid chondrosarcoma",
    "source": "DOID",
    "definition": "An extraosseous chondrosarcoma that has_material_basis_in cells derived from transformed cells that produce cartilage and is characterized by a marked abundance of extracellular mucoid (myxoid) matrix. [url:http\\://en.wikipedia.org/wiki/Chondrosarcoma, url:http\\://en.wikipedia.org/wiki/Myxoid_chondrosarcoma, url:http\\://en.wikipedia.org/wiki/Myxoid_tumor, url:https\\://www.ncbi.nlm.nih.gov/pubmed/10564384]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:6496",
    "evidence": [
        {
            "id": 12930,
            "approvalStatus": "Guideline",
            "evidenceType": "Diagnostic",
            "efficacyEvidence": "EWSR1-NR4A3 fusions aid the diagnosis of extraskeletal myxoid chondrosarcoma (NCCN.org).",
            "molecularProfile": {
                "id": 14056,
                "profileName": "EWSR1 - NR4A3"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 6496,
                "name": "extraskeletal myxoid chondrosarcoma",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 10889,
                    "pubMedId": null,
                    "title": "NCCN.org",
                    "url": "https://www.nccn.org/professionals/physician_gls/default.aspx"
                }
            ],
            "ampCapAscoEvidenceLevel": "A",
            "ampCapAscoInferredTier": "I"
        },
        {
            "id": 13052,
            "approvalStatus": "Guideline",
            "evidenceType": "Diagnostic",
            "efficacyEvidence": "TAF15-NR4A3 fusions aid the diagnosis of extraskeletal myxoid chondrosarcoma (NCCN.org).",
            "molecularProfile": {
                "id": 28982,
                "profileName": "TAF15 - NR4A3"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 6496,
                "name": "extraskeletal myxoid chondrosarcoma",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 10889,
                    "pubMedId": null,
                    "title": "NCCN.org",
                    "url": "https://www.nccn.org/professionals/physician_gls/default.aspx"
                }
            ],
            "ampCapAscoEvidenceLevel": "A",
            "ampCapAscoInferredTier": "I"
        },
        {
            "id": 13054,
            "approvalStatus": "Guideline",
            "evidenceType": "Diagnostic",
            "efficacyEvidence": "TCF12-NR4A3 fusions aid the diagnosis of extraskeletal myxoid chondrosarcoma (NCCN.org).",
            "molecularProfile": {
                "id": 28984,
                "profileName": "TCF12 - NR4A3"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 6496,
                "name": "extraskeletal myxoid chondrosarcoma",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 10889,
                    "pubMedId": null,
                    "title": "NCCN.org",
                    "url": "https://www.nccn.org/professionals/physician_gls/default.aspx"
                }
            ],
            "ampCapAscoEvidenceLevel": "A",
            "ampCapAscoInferredTier": "I"
        },
        {
            "id": 20073,
            "approvalStatus": "Guideline",
            "evidenceType": "Diagnostic",
            "efficacyEvidence": "TFG-NR4A3 fusions aid the diagnosis of extraskeletal myxoid chondrosarcoma (NCCN.org).",
            "molecularProfile": {
                "id": 34805,
                "profileName": "TFG - NR4A3"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 6496,
                "name": "extraskeletal myxoid chondrosarcoma",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 10889,
                    "pubMedId": null,
                    "title": "NCCN.org",
                    "url": "https://www.nccn.org/professionals/physician_gls/default.aspx"
                }
            ],
            "ampCapAscoEvidenceLevel": "A",
            "ampCapAscoInferredTier": "I"
        }
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT02601937",
            "title": "A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma",
            "phase": "Phase I",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 2683,
                    "therapyName": "Tazemetostat",
                    "synonyms": null
                }
            ]
        }
    ]
}